{"id":55029,"date":"2026-01-22T01:38:00","date_gmt":"2026-01-21T17:38:00","guid":{"rendered":"https:\/\/flcube.com\/?p=55029"},"modified":"2026-01-22T01:38:01","modified_gmt":"2026-01-21T17:38:01","slug":"eyebright-medical-to-acquire-control-of-delta-medical-in-143-m-sports-medicine-deal","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=55029","title":{"rendered":"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal"},"content":{"rendered":"\n<p><strong>Eyebright Medical Technology Co., Ltd<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/688050:SHA\">SHA: 688050<\/a>) announced plans to acquire a <strong>controlling stake of at least 51%<\/strong> in <strong>Delta Medical<\/strong>, a sports\u2011medicine specialist, in a transaction valued at up to <strong>RMB\u202f1\u202fbillion (USD\u202f143\u202fmillion)<\/strong>. The deal will be funded through a mix of acquisition financing and internal funds, broadening Eyebright\u2019s healthcare footprint and creating synergies across R&amp;D, manufacturing, and sales.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-deal-overview\">Deal Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Acquirer<\/strong><\/td><td>Eyebright Medical Technology Co., Ltd (688050.SH)<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Delta Medical (sports\u2011medicine specialist)<\/td><\/tr><tr><td>**Stake<\/td><td>Minimum 51% (controlling)<\/td><\/tr><tr><td>**Valuation<\/td><td>Up to RMB\u202f1\u202fbillion (USD\u202f143\u202fmillion)<\/td><\/tr><tr><td>**Funding<\/td><td>Acquisition financing + internal funds<\/td><\/tr><tr><td>**Expected Close<\/td><td>Q2\u202f2026 (subject to due diligence and regulatory approvals)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-target-profile-delta-medical\">Target Profile: Delta Medical<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Attribute<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td>**Founded<\/td><td>2016<\/td><\/tr><tr><td>**Business Focus<\/td><td>Integrated med\u2011tech group covering prevention, surgical treatment, rehabilitation<\/td><\/tr><tr><td>**Product Portfolio<\/td><td>Sports\u2011medicine implants, surgical tools, arthroscopy devices, rehabilitation equipment<\/td><\/tr><tr><td>**Operations<\/td><td>Full\u2011cycle: R&amp;D, production, sales, and service<\/td><\/tr><tr><td>**Market Position<\/td><td>Leading domestic sports\u2011medicine platform<\/td><\/tr><tr><td><strong>Revenue (2025E)<\/strong><\/td><td>RMB\u202f350\u2011400\u202fmillion (USD\u202f50\u201157\u202fmillion)<\/td><\/tr><tr><td>**Growth Rate<\/td><td>25\u201130% CAGR (2023\u20112025)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-amp-synergies\">Strategic Rationale &amp; Synergies<\/h2>\n\n\n\n<p><strong>For Eyebright Medical:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Expansion:<\/strong> Enters <strong>high\u2011growth sports\u2011medicine segment<\/strong>, complementing core biomedical materials and high\u2011end devices business<\/li>\n\n\n\n<li><strong>Vertical Integration:<\/strong> Combines Eyebright\u2019s <strong>biomaterials expertise<\/strong> with Delta\u2019s <strong>implant and device platforms<\/strong><\/li>\n\n\n\n<li><strong>Manufacturing Scale:<\/strong> Leverages Eyebright\u2019s <strong>GMP\u2011certified facilities<\/strong> for Delta\u2019s product expansion<\/li>\n\n\n\n<li><strong>Sales Synergy:<\/strong> Cross\u2011selling opportunities via Eyebright\u2019s <strong>3,000\u2011hospital distribution network<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>For Delta Medical:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Capital Infusion:<\/strong> Funds R&amp;D for next\u2011generation arthroscopy robots and bioabsorbable implants<\/li>\n\n\n\n<li><strong>Global Access:<\/strong> Eyebright\u2019s platform accelerates <strong>international registration<\/strong> (CE, FDA) for Delta\u2019s products<\/li>\n\n\n\n<li><strong>Operational Efficiency:<\/strong> Shared back\u2011office functions reduce overhead costs by an estimated <strong>15\u201120%<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-context-amp-financial-projections\">Market Context &amp; Financial Projections<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>China Sports Medicine Market<\/th><th>Global Market<\/th><\/tr><\/thead><tbody><tr><td><strong>Market Size (2025E)<\/strong><\/td><td>\u00a518\u202fbillion ($2.6\u202fbillion)<\/td><td>$8.5\u202fbillion<\/td><\/tr><tr><td><strong>Growth Rate<\/strong><\/td><td>12\u201115% CAGR<\/td><td>8\u201110% CAGR<\/td><\/tr><tr><td><strong>Key Drivers<\/strong><\/td><td>Rising sports injuries, aging population, minimally invasive surgery adoption<\/td><td><\/td><\/tr><tr><td><strong>Combined Revenue (2027E)<\/strong><\/td><td>RMB\u202f1.2\u202fbillion<\/td><td>\u2013<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>28\u201132% (post\u2011synergies)<\/td><td>\u2013<\/td><\/tr><tr><td><strong>Deal Accretion<\/strong><\/td><td>EPS accretive by 2028<\/td><td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Valuation Rationale:<\/strong> <strong>RMB\u202f1\u202fbillion<\/strong> represents <strong>2.5\u20113.0x 2025E revenue<\/strong>, in line with med\u2011tech M&amp;A multiples<\/li>\n\n\n\n<li><strong>Synergy Value:<\/strong> Estimated <strong>RMB\u202f150\u2011200\u202fmillion<\/strong> in annual cost and revenue synergies by 2027<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding acquisition completion, synergy realization, and market expansion. Actual results may differ due to regulatory approvals, integration challenges, and competitive dynamics in the sports\u2011medicine sector.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/688050_20260121_ZCMU.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of 688050_20260121_ZCMU.\"><\/object><a id=\"wp-block-file--media-6c9cc619-3f40-45ba-9deb-6f051378dc5e\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/688050_20260121_ZCMU.pdf\">688050_20260121_ZCMU<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/688050_20260121_ZCMU.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-6c9cc619-3f40-45ba-9deb-6f051378dc5e\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Eyebright Medical Technology Co., Ltd (SHA: 688050) announced plans to acquire a controlling stake of&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4565,2343,2345],"class_list":["post-55029","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-delta-medical","tag-eyebright-medical-technology","tag-sha-688050"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Eyebright Medical Technology Co., Ltd (SHA: 688050) announced plans to acquire a controlling stake of at least 51% in Delta Medical, a sports\u2011medicine specialist, in a transaction valued at up to RMB\u202f1\u202fbillion (USD\u202f143\u202fmillion). The deal will be funded through a mix of acquisition financing and internal funds, broadening Eyebright\u2019s healthcare footprint and creating synergies across R&amp;D, manufacturing, and sales.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=55029\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal\" \/>\n<meta property=\"og:description\" content=\"Eyebright Medical Technology Co., Ltd (SHA: 688050) announced plans to acquire a controlling stake of at least 51% in Delta Medical, a sports\u2011medicine specialist, in a transaction valued at up to RMB\u202f1\u202fbillion (USD\u202f143\u202fmillion). The deal will be funded through a mix of acquisition financing and internal funds, broadening Eyebright\u2019s healthcare footprint and creating synergies across R&amp;D, manufacturing, and sales.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=55029\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-21T17:38:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-21T17:38:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55029#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55029\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal\",\"datePublished\":\"2026-01-21T17:38:00+00:00\",\"dateModified\":\"2026-01-21T17:38:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55029\"},\"wordCount\":395,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Delta Medical\",\"Eyebright Medical Technology\",\"SHA: 688050\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55029#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55029\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=55029\",\"name\":\"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-21T17:38:00+00:00\",\"dateModified\":\"2026-01-21T17:38:01+00:00\",\"description\":\"Eyebright Medical Technology Co., Ltd (SHA: 688050) announced plans to acquire a controlling stake of at least 51% in Delta Medical, a sports\u2011medicine specialist, in a transaction valued at up to RMB\u202f1\u202fbillion (USD\u202f143\u202fmillion). The deal will be funded through a mix of acquisition financing and internal funds, broadening Eyebright\u2019s healthcare footprint and creating synergies across R&D, manufacturing, and sales.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55029#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=55029\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=55029#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal - Insight, China&#039;s Pharmaceutical Industry","description":"Eyebright Medical Technology Co., Ltd (SHA: 688050) announced plans to acquire a controlling stake of at least 51% in Delta Medical, a sports\u2011medicine specialist, in a transaction valued at up to RMB\u202f1\u202fbillion (USD\u202f143\u202fmillion). The deal will be funded through a mix of acquisition financing and internal funds, broadening Eyebright\u2019s healthcare footprint and creating synergies across R&D, manufacturing, and sales.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=55029","og_locale":"en_US","og_type":"article","og_title":"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal","og_description":"Eyebright Medical Technology Co., Ltd (SHA: 688050) announced plans to acquire a controlling stake of at least 51% in Delta Medical, a sports\u2011medicine specialist, in a transaction valued at up to RMB\u202f1\u202fbillion (USD\u202f143\u202fmillion). The deal will be funded through a mix of acquisition financing and internal funds, broadening Eyebright\u2019s healthcare footprint and creating synergies across R&D, manufacturing, and sales.","og_url":"https:\/\/flcube.com\/?p=55029","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-21T17:38:00+00:00","article_modified_time":"2026-01-21T17:38:01+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=55029#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=55029"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal","datePublished":"2026-01-21T17:38:00+00:00","dateModified":"2026-01-21T17:38:01+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=55029"},"wordCount":395,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Delta Medical","Eyebright Medical Technology","SHA: 688050"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=55029#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=55029","url":"https:\/\/flcube.com\/?p=55029","name":"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-21T17:38:00+00:00","dateModified":"2026-01-21T17:38:01+00:00","description":"Eyebright Medical Technology Co., Ltd (SHA: 688050) announced plans to acquire a controlling stake of at least 51% in Delta Medical, a sports\u2011medicine specialist, in a transaction valued at up to RMB\u202f1\u202fbillion (USD\u202f143\u202fmillion). The deal will be funded through a mix of acquisition financing and internal funds, broadening Eyebright\u2019s healthcare footprint and creating synergies across R&D, manufacturing, and sales.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=55029#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=55029"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=55029#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Eyebright Medical to Acquire Control of Delta Medical in $143\u202fM Sports\u2011Medicine Deal"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55029"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55029\/revisions"}],"predecessor-version":[{"id":55031,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/55029\/revisions\/55031"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}